Predictive Oncology Inc (POAI)

03:09 AM

Predictive Oncology (NASDAQ:POAI) Stock Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World

03:09 AM

Jun 05, 2025

Major AI Breakthrough in Cancer Research: Leading Pharma Companies Unite in Revolutionary Oncology Initiative - Stock Titan

Jun 05, 2025

Jun 02, 2025

SEC Form 424B5 filed by Predictive Oncology Inc. - Quantisnow

Jun 02, 2025

Jun 01, 2025

'It's not something you choose to do, it's something you have to do': CEO & artist shares story - WTAE

Jun 01, 2025

May 30, 2025

Predictive Oncology (NASDAQ:POAI) Stock Crosses Below 200 Day Moving Average – Time to Sell? - Defense World

May 30, 2025

May 27, 2025

Court Denies Renovaro Motion for an Expedited Trial in July - GlobeNewswire

May 27, 2025

May 27, 2025

Predictive Oncology says court denies Renovaro motion for expedited trial - TipRanks

May 27, 2025

May 27, 2025

Predictive Oncology to defend against Renovaro’s claims in court By Investing.com - Investing.com Canada

May 27, 2025

May 27, 2025

Predictive Oncology (POAI) Addresses Legal Dispute with Renovaro - GuruFocus

May 27, 2025

May 27, 2025

Predictive Oncology to defend against Renovaro’s claims in court - Investing.com Australia

May 27, 2025

May 27, 2025

Court Denies Renovaro Motion for an Expedited Trial in July | POAI Stock News - GuruFocus

May 27, 2025

May 27, 2025

Delaware Court Rejects Renovaro's Rush to Trial Against Predictive Oncology, Cites Critical Delays - Stock Titan

May 27, 2025

May 23, 2025

Renovaro Inc. Accelerates 2025 Lawsuit to Force Predictive Oncology Merger - MSN

May 23, 2025

May 22, 2025

Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish By Stocktwits - Investing.com India

May 22, 2025

May 22, 2025

UPDATERenovaro Inc. Announces Expedited Trial for 2025 Lawsui - GuruFocus

May 22, 2025

May 22, 2025

Predictive Oncology (POAI) Advances AI-Driven Cancer Drug Discov - GuruFocus

May 22, 2025

May 22, 2025

Renovaro Sues Predictive Oncology (POAI) Over Merger Agreement D - GuruFocus

May 22, 2025

May 22, 2025

Renovaro Gets Expedited Trial in Predictive Oncology Merger Dispute - marketscreener.com

May 22, 2025

May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - The Manila Times

May 22, 2025

May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology | RENB Stock News - GuruFocus

May 22, 2025

May 22, 2025

Renovaro Inc. Secures Ruling to Expedite Trial Against Predictive Oncology Over Breach of Merger Agreement - Nasdaq

May 22, 2025

May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to - GlobeNewswire

May 22, 2025

May 22, 2025

Court Fast-Tracks Renovaro's Lawsuit to Force Predictive Oncology Merger After 50% Stock Jump Drama - Stock Titan

May 22, 2025

May 22, 2025

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition | POAI Stock News - GuruFocus

May 22, 2025

May 22, 2025

Predictive Oncology harnesses AI for drug discovery - Investing.com

May 22, 2025

May 22, 2025

Predictive Oncology moves to leverage biobank using AI - TipRanks

May 22, 2025

May 22, 2025

Predictive Oncology harnesses AI for drug discovery By Investing.com - Investing.com Nigeria

May 22, 2025

May 22, 2025

Predictive Oncology Inc. Advances AI-Driven Drug Discovery with Extensive Biobank of Tumor Samples - Nasdaq

May 22, 2025

May 22, 2025

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition - GlobeNewswire

May 22, 2025

May 22, 2025

Major AI Breakthrough: How 150,000 Live Tumor Samples Are Revolutionizing Cancer Drug Discovery - Stock Titan

May 22, 2025

May 20, 2025

Predictive Oncology issued shareholder letter - TipRanks

May 20, 2025

May 20, 2025

Predictive Oncology (POAI) Showcases Recent Achievements and Future Plans | POAI Stock News - GuruFocus

May 20, 2025

May 20, 2025

Predictive Oncology Inc. Issues Shareholder Letter Titled, - GuruFocus

May 20, 2025

May 20, 2025

Predictive Oncology Expands AI-Driven Platform to Include Biomarker Discovery and Drug Repurposing for Precision Oncology - Nasdaq

May 20, 2025

May 20, 2025

Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: ... - Bluefield Daily Telegraph

May 20, 2025

May 20, 2025

Revolutionary AI Platform Expands into $14.5B Biomarker Market with Game-Changing Cancer Prediction Technology - Stock Titan

May 20, 2025

May 19, 2025

Predictive Oncology reports loss, but has "meaningfully expanded the potential" of its AI platform - The Business Journals

May 19, 2025

May 16, 2025

Predictive Oncology Inc. Reports Q1 2025 Earnings - TipRanks

May 16, 2025

May 16, 2025

Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 16, 2025

May 15, 2025

Predictive Oncology (POAI) Sees Significant Revenue Growth in Q1 2025 | POAI Stock News - GuruFocus

May 15, 2025

May 15, 2025

Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update | POAI Stock News - GuruFocus

May 15, 2025

May 15, 2025

Predictive Oncology Reports Q1 2025 Financial Results and Corporate Developments - Nasdaq

May 15, 2025

May 12, 2025

Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies - GlobeNewswire

May 12, 2025

May 11, 2025

Predictive Oncology (POAI) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025

Apr 27, 2025

Head-To-Head Review: Pathfinder Cell Therapy (OTCMKTS:PFND) versus Predictive Oncology (NASDAQ:POAI) - Defense World

Apr 27, 2025